Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 5, 2014, after the close
10-Q filed Nov 5, 2014, 36 days after period end · 0001299130-14-000080
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $20.62M | $7.42M | $2.78M | $10.52M |
| Net Income | -$9.16M | -$20.49M | -$22.73M | -$29.28M |
| EPS Diluted | -$0.13 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.31 |
| -$0.41 |
| -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
